Could a common ADHD drug improve speech in kids with apraxia?
NCT ID NCT05185583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether methylphenidate, a drug often used for ADHD, can help children aged 6 to 12 with childhood apraxia of speech speak more clearly. The trial involved 18 children who took the drug or a placebo in a crossover design. The main goal was to see if the drug improved how well others could understand their speech.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD APRAXIA OF SPEECH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New speech therapy approach tested for kids with apraxia
- New speech therapy shows promise for kids with apraxia
- New therapy aims to help kids with speech disorder speak in phrases
- Parent training boosts speech therapy for kids with apraxia
- New speech therapy shows promise for kids with apraxia
- Could a fish oil supplement help kids with speech apraxia?